153 related articles for article (PubMed ID: 29368096)
1. Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2018 Sep; 446(1-2):105-114. PubMed ID: 29368096
[TBL] [Abstract][Full Text] [Related]
2. RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2020 Jan; 464(1-2):51-63. PubMed ID: 31754973
[TBL] [Abstract][Full Text] [Related]
3. An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
Xylinas E; Hassler MR; Zhuang D; Krzywinski M; Erdem Z; Robinson BD; Elemento O; Clozel T; Shariat SF
Biomolecules; 2016 Sep; 6(3):. PubMed ID: 27598218
[TBL] [Abstract][Full Text] [Related]
4. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
Nelson N; Clark GJ
Oncotarget; 2016 Jun; 7(23):33821-31. PubMed ID: 27034171
[TBL] [Abstract][Full Text] [Related]
5. [The Study of Decitabine Effect on the Endometrial Carcinoma Xenografted in Nude Mice.].
Li RH; Wang XP; Liu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):843-847. PubMed ID: 28598109
[TBL] [Abstract][Full Text] [Related]
6. 5-azacytidine reverses drug resistance in bladder cancer cells.
Ramachandran K; Gordian E; Singal R
Anticancer Res; 2011 Nov; 31(11):3757-66. PubMed ID: 22110197
[TBL] [Abstract][Full Text] [Related]
7. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions.
Donninger H; Allen N; Henson A; Pogue J; Williams A; Gordon L; Kassler S; Dunwell T; Latif F; Clark GJ
J Biol Chem; 2011 May; 286(21):18483-91. PubMed ID: 21489991
[TBL] [Abstract][Full Text] [Related]
8. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
[TBL] [Abstract][Full Text] [Related]
9. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
Liu X; Dai X; Wu B
Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
[TBL] [Abstract][Full Text] [Related]
10. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
Ramakrishnan S; Hu Q; Krishnan N; Wang D; Smit E; Granger V; Rak M; Attwood K; Johnson C; Morrison C; Pili R; Chatta G; Guru K; Gueron G; McNally L; Wang J; Woloszynska-Read A
Cell Death Dis; 2017 Dec; 8(12):3217. PubMed ID: 29242529
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
[TBL] [Abstract][Full Text] [Related]
12. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
Zhao QZ; Dou KF
J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856
[TBL] [Abstract][Full Text] [Related]
13. Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells.
Chang FL; Lai MD
J Urol; 2001 Jul; 166(1):304-10. PubMed ID: 11435891
[TBL] [Abstract][Full Text] [Related]
14. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
Zuo S; Chen Y; Xu L; Tang Q; Zou S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
[TBL] [Abstract][Full Text] [Related]
15. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
16. How Hippo Signaling Pathway Modulates Cardiovascular Development and Diseases.
Zhou W; Zhao M
J Immunol Res; 2018; 2018():3696914. PubMed ID: 29577047
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of Hippo signalling pathway in bladder cancer.
Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
[TBL] [Abstract][Full Text] [Related]
19. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]